Signals for stress erythropoiesis are integrated via an erythropoietin receptor-phosphotyrosine-343-Stat5 axis

The Journal of Clinical Investigation
Madhu P MenonD M Wojchowski

Abstract

Anemia due to chronic disease or chemotherapy often is ameliorated by erythropoietin (Epo). Present studies reveal that, unlike steady-state erythropoiesis, erythropoiesis during anemia depends sharply on an Epo receptor-phosphotyrosine-343-Stat5 signaling axis. In mice expressing a phosphotyrosine-null (PY-null) Epo receptor allele (EpoR-HM), severe and persistent anemia was induced by hemolysis or 5-fluorouracil. In short-term transplantation experiments, donor EpoR-HM bone marrow cells also failed to efficiently repopulate the erythroid compartment. In each context, stress erythropoiesis was rescued to WT levels upon the selective restoration of an EpoR PY343 Stat5-binding site (EpoR-H allele). As studied using a unique primary culture system, EpoR-HM erythroblasts exhibited marked stage-specific losses in Epo-dependent growth and survival. EpoR-H PY343 signals restored efficient erythroblast expansion, and the selective Epo induction of the Stat5 target genes proviral integration site-1 (Pim-1) and oncostatin-M. Bcl2-like 1 (Bcl-x), in contrast, was not significantly induced via WT-EpoR, EpoR-HM, or EpoR-H alleles. In Kit+ CD71+ erythroblasts, EpoR-PY343 signals furthermore enhanced SCF growth effects, and SCF modulation of...Continue Reading

References

Mar 7, 1996·The New England Journal of Medicine·C Lacombe
Mar 14, 1997·The Journal of Biological Chemistry·S M Jacobs-HelberS T Sawyer
Apr 1, 1997·Proceedings of the National Academy of Sciences of the United States of America·U KlingmüllerH F Lodish
Jun 8, 1999·The Journal of Biological Chemistry·M F BrizziL Pegoraro
Feb 7, 2001·Proceedings of the National Academy of Sciences of the United States of America·V DivokyJ T Prchal
May 25, 2002·European Journal of Biochemistry·Michael HörtnerSerge Haan
Oct 25, 2002·Journal of Interferon & Cytokine Research : the Official Journal of the International Society for Interferon and Cytokine Research·Armin G Jegalian, Hong Wu
Jul 19, 2003·Genes & Development·Casey J FoxCraig B Thompson
Aug 12, 2003·The Journal of Biological Chemistry·Ke LiDon Wojchowski
Nov 11, 2003·The Journal of Biological Chemistry·Samuel Wormald, Douglas J Hilton
Jul 9, 2004·FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology·Christina WarneckeKai-Uwe Eckardt
Aug 27, 2004·American Journal of Physiology. Cell Physiology·Qin TongBarbara A Miller
Dec 14, 2004·Blood·Laurie E LenoxRobert F Paulson
Jan 6, 2005·JAMA : the Journal of the American Medical Association·Kenneth MaieseZhao Zhong Chong
Jan 12, 2005·The Journal of Experimental Medicine·Casey J FoxCraig B Thompson
Feb 11, 2005·The New England Journal of Medicine·Alan ListJerome B Zeldis
Mar 9, 2005·Trends in Cell Biology·Terri D RichmondDwayne L Barber
Mar 31, 2005·Molecular Cancer Research : MCR·Kate Petersen ShayNancy S Magnuson
Apr 21, 2005·JAMA : the Journal of the American Medical Association·Leonard Sadoff

❮ Previous
Next ❯

Citations

Jun 28, 2008·Apoptosis : an International Journal on Programmed Cell Death·Abhinav DiwanGerald W Dorn
Jun 7, 2012·The Journal of Biological Chemistry·Mojib JavadiDwayne L Barber
Oct 16, 2008·The Journal of Biological Chemistry·Olga BogachevaDon M Wojchowski
Jan 16, 2013·The Journal of Experimental Medicine·Arvind DevDon M Wojchowski
Apr 7, 2007·Current Opinion in Hematology·Merav Socolovsky
Feb 23, 2010·Current Opinion in Hematology·Don M WojchowskiArvind Dev
Mar 3, 2006·The Journal of Clinical Investigation·Gregory D Longmore
Sep 14, 2011·The Journal of Clinical Investigation·Nariaki AsadaMotoko Yanagita
Apr 4, 2007·Blood·Pradeep SathyanarayanaDon M Wojchowski
Feb 2, 2008·Blood·Florian GrebienRichard Moriggl
Mar 20, 2008·Blood·Pradeep SathyanarayanaDon M Wojchowski
Aug 13, 2008·Blood·Marc A KerenyiErnst W Müllner
Apr 18, 2012·Blood·Pradeep SathyanarayanaDon M Wojchowski
Jan 1, 2009·Mediterranean Journal of Hematology and Infectious Diseases·Marco Gabbianelli, Ugo Testa
Apr 23, 2013·TheScientificWorldJournal·Jean-Antoine RibeilOlivier Hermine
Feb 18, 2010·Expert Opinion on Emerging Drugs·Ugo Testa
Aug 9, 2011·International Journal of Cardiology·Darlington O OkonkoMyrtle Y Gordon
Apr 18, 2014·Science China. Life Sciences·Cong CaoDePei Liu
Apr 9, 2008·Progress in Neurobiology·Kenneth MaieseYan Chen Shang
Jul 28, 2007·Critical Reviews in Oncology/hematology·Vivien M HodgesA Peter Maxwell
Apr 25, 2009·British Journal of Haematology·Francesca Merchionne, Franco Dammacco
Jan 26, 2010·British Journal of Haematology·Lily J HuangGamze B Bulut
Nov 29, 2013·Journal of Cellular and Molecular Medicine·Sanja VignjevićGordana Jovčić
Jun 17, 2016·Molecular & Cellular Oncology·Fabienne Brenet, Joseph M Scandura
Mar 10, 2006·Blood Cells, Molecules & Diseases·Don M WojchowskiOleg Bogachev
Apr 19, 2015·Blood·David Kuhrt, Don M Wojchowski

❮ Previous
Next ❯

Methods Mentioned

BETA
ubiquitination
fluorescence-activated cell sorting
flow cytometry
PCR

Related Concepts

Related Feeds

Anemia

Anemia develops when your blood lacks enough healthy red blood cells. Anemia of inflammation (AI, also called anemia of chronic disease) is a common, typically normocytic, normochromic anemia that is caused by an underlying inflammatory disease. Here is the latest research on anemia.

BCL-2 Family Proteins

BLC-2 family proteins are a group that share the same homologous BH domain. They play many different roles including pro-survival signals, mitochondria-mediated apoptosis and removal or damaged cells. They are often regulated by phosphorylation, affecting their catalytic activity. Here is the latest research on BCL-2 family proteins.